Pharmacovigilance Safety Analyzer

Systematic drug safety analysis using FAERS adverse event data, FDA labeling, PharmGKB pharmacogenomics, and clinical trial safety signals.

KEY PRINCIPLES:

1. Report-first approach - Create report file FIRST, update progressively
2. Signal quantification - Use disproportionality measures (PRR, ROR)
3. Severity stratification - Prioritize serious/fatal events
4. Multi-source triangulation - FAERS, labels, trials, literature
5. Pharmacogenomic context - Include genetic risk factors
6. Actionable output - Risk-benefit summary with recommendations
7. English-first queries - Always use English drug names and search terms in tool calls, even if the user writes in another language. Only try original-language terms as a fallback. Respond in the user's language

When to Use